Alexithymia in Patients With Substance Use Disorders and Its Relationship With Psychiatric Comorbidities and Health-Related Quality of Life

Background: Alexithymia frequently correlates with several psychiatric disorders, including substance use disorder (SUD). However, most studies reporting the associations between alexithymia and psychiatric disorders have been performed in populations without SUD. This research, therefore, evaluates...

Full description

Bibliographic Details
Main Authors: Raul F. Palma-Álvarez, Elena Ros-Cucurull, Constanza Daigre, Marta Perea-Ortueta, Pedro Serrano-Pérez, Nieves Martínez-Luna, Anna Salas-Martínez, María Robles-Martínez, Josep A. Ramos-Quiroga, Carlos Roncero, Lara Grau-López
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2021.659063/full
_version_ 1818411041835450368
author Raul F. Palma-Álvarez
Raul F. Palma-Álvarez
Raul F. Palma-Álvarez
Raul F. Palma-Álvarez
Elena Ros-Cucurull
Elena Ros-Cucurull
Elena Ros-Cucurull
Elena Ros-Cucurull
Constanza Daigre
Constanza Daigre
Constanza Daigre
Constanza Daigre
Marta Perea-Ortueta
Marta Perea-Ortueta
Pedro Serrano-Pérez
Pedro Serrano-Pérez
Pedro Serrano-Pérez
Nieves Martínez-Luna
Anna Salas-Martínez
María Robles-Martínez
María Robles-Martínez
Josep A. Ramos-Quiroga
Josep A. Ramos-Quiroga
Josep A. Ramos-Quiroga
Josep A. Ramos-Quiroga
Carlos Roncero
Carlos Roncero
Lara Grau-López
Lara Grau-López
Lara Grau-López
Lara Grau-López
author_facet Raul F. Palma-Álvarez
Raul F. Palma-Álvarez
Raul F. Palma-Álvarez
Raul F. Palma-Álvarez
Elena Ros-Cucurull
Elena Ros-Cucurull
Elena Ros-Cucurull
Elena Ros-Cucurull
Constanza Daigre
Constanza Daigre
Constanza Daigre
Constanza Daigre
Marta Perea-Ortueta
Marta Perea-Ortueta
Pedro Serrano-Pérez
Pedro Serrano-Pérez
Pedro Serrano-Pérez
Nieves Martínez-Luna
Anna Salas-Martínez
María Robles-Martínez
María Robles-Martínez
Josep A. Ramos-Quiroga
Josep A. Ramos-Quiroga
Josep A. Ramos-Quiroga
Josep A. Ramos-Quiroga
Carlos Roncero
Carlos Roncero
Lara Grau-López
Lara Grau-López
Lara Grau-López
Lara Grau-López
author_sort Raul F. Palma-Álvarez
collection DOAJ
description Background: Alexithymia frequently correlates with several psychiatric disorders, including substance use disorder (SUD). However, most studies reporting the associations between alexithymia and psychiatric disorders have been performed in populations without SUD. This research, therefore, evaluates alexithymia in Spanish patients with SUD and the relationship among alexithymia, psychiatric comorbidities, psychological symptoms/traits, SUD variables, and health-related quality of life (HRQoL).Methodology: A cross-sectional study was conducted with 126 Spanish outpatients with SUD (75.4% males; mean age 43.72 ± 14.61 years), correlating their alexithymia levels (using the Toronto Alexithymia Scale 20 [TAS-20]) to their psychiatric comorbidities, psychological symptoms/traits, SUD variables, and HRQoL.Results: Alexithymia was significantly higher in patients who had cannabis use disorder. Higher alexithymia scores were also related to higher levels of depression, anxiety, impulsivity, and lower HRQoL. After multivariate analysis, trait anxiety, impulsivity, and the physical component summary of the HRQoL were found to be independently related to alexithymia.Conclusions: SUD patients with higher alexithymia levels have more frequently psychiatric comorbidities, present specific psychological features, and have worse HRQoL. Hence, it is important to evaluate these factors and offer more accurate psychotherapeutic approaches for this patient population.
first_indexed 2024-12-14T10:25:07Z
format Article
id doaj.art-dce8bbda99ce4e4f8ec8d96e2a496d25
institution Directory Open Access Journal
issn 1664-0640
language English
last_indexed 2024-12-14T10:25:07Z
publishDate 2021-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychiatry
spelling doaj.art-dce8bbda99ce4e4f8ec8d96e2a496d252022-12-21T23:06:24ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402021-04-011210.3389/fpsyt.2021.659063659063Alexithymia in Patients With Substance Use Disorders and Its Relationship With Psychiatric Comorbidities and Health-Related Quality of LifeRaul F. Palma-Álvarez0Raul F. Palma-Álvarez1Raul F. Palma-Álvarez2Raul F. Palma-Álvarez3Elena Ros-Cucurull4Elena Ros-Cucurull5Elena Ros-Cucurull6Elena Ros-Cucurull7Constanza Daigre8Constanza Daigre9Constanza Daigre10Constanza Daigre11Marta Perea-Ortueta12Marta Perea-Ortueta13Pedro Serrano-Pérez14Pedro Serrano-Pérez15Pedro Serrano-Pérez16Nieves Martínez-Luna17Anna Salas-Martínez18María Robles-Martínez19María Robles-Martínez20Josep A. Ramos-Quiroga21Josep A. Ramos-Quiroga22Josep A. Ramos-Quiroga23Josep A. Ramos-Quiroga24Carlos Roncero25Carlos Roncero26Lara Grau-López27Lara Grau-López28Lara Grau-López29Lara Grau-López30Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, SpainDepartment of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Bellaterra, SpainGroup of Psychiatry, Mental Health and Addiction, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, SpainBiomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, SpainDepartment of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, SpainDepartment of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Bellaterra, SpainGroup of Psychiatry, Mental Health and Addiction, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, SpainBiomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, SpainDepartment of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, SpainDepartment of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Bellaterra, SpainGroup of Psychiatry, Mental Health and Addiction, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, SpainBiomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, SpainDepartment of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, SpainGroup of Psychiatry, Mental Health and Addiction, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, SpainDepartment of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, SpainDepartment of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Bellaterra, SpainGroup of Psychiatry, Mental Health and Addiction, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, SpainDepartment of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, SpainDepartment of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, SpainInstitute of Neuropsychiatry and Addictions (INAD), Parc de Salut Mar, Barcelona, SpainHospital del Mar Institute for Biomedical Research (IMIM), Barcelona, SpainDepartment of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, SpainDepartment of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Bellaterra, SpainGroup of Psychiatry, Mental Health and Addiction, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, SpainBiomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, SpainPsychiatry Service, University of Salamanca Health Care Complex, Insitute of Biomedicine, Salamanca, SpainPsychiatry Unit, School of Medicine, University of Salamanca, Salamanca, SpainDepartment of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, SpainDepartment of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Bellaterra, SpainGroup of Psychiatry, Mental Health and Addiction, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, SpainBiomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, SpainBackground: Alexithymia frequently correlates with several psychiatric disorders, including substance use disorder (SUD). However, most studies reporting the associations between alexithymia and psychiatric disorders have been performed in populations without SUD. This research, therefore, evaluates alexithymia in Spanish patients with SUD and the relationship among alexithymia, psychiatric comorbidities, psychological symptoms/traits, SUD variables, and health-related quality of life (HRQoL).Methodology: A cross-sectional study was conducted with 126 Spanish outpatients with SUD (75.4% males; mean age 43.72 ± 14.61 years), correlating their alexithymia levels (using the Toronto Alexithymia Scale 20 [TAS-20]) to their psychiatric comorbidities, psychological symptoms/traits, SUD variables, and HRQoL.Results: Alexithymia was significantly higher in patients who had cannabis use disorder. Higher alexithymia scores were also related to higher levels of depression, anxiety, impulsivity, and lower HRQoL. After multivariate analysis, trait anxiety, impulsivity, and the physical component summary of the HRQoL were found to be independently related to alexithymia.Conclusions: SUD patients with higher alexithymia levels have more frequently psychiatric comorbidities, present specific psychological features, and have worse HRQoL. Hence, it is important to evaluate these factors and offer more accurate psychotherapeutic approaches for this patient population.https://www.frontiersin.org/articles/10.3389/fpsyt.2021.659063/fullalexithymiaanxietydepressionhealth-related quality of lifeimpulsivitysubstance use disorder
spellingShingle Raul F. Palma-Álvarez
Raul F. Palma-Álvarez
Raul F. Palma-Álvarez
Raul F. Palma-Álvarez
Elena Ros-Cucurull
Elena Ros-Cucurull
Elena Ros-Cucurull
Elena Ros-Cucurull
Constanza Daigre
Constanza Daigre
Constanza Daigre
Constanza Daigre
Marta Perea-Ortueta
Marta Perea-Ortueta
Pedro Serrano-Pérez
Pedro Serrano-Pérez
Pedro Serrano-Pérez
Nieves Martínez-Luna
Anna Salas-Martínez
María Robles-Martínez
María Robles-Martínez
Josep A. Ramos-Quiroga
Josep A. Ramos-Quiroga
Josep A. Ramos-Quiroga
Josep A. Ramos-Quiroga
Carlos Roncero
Carlos Roncero
Lara Grau-López
Lara Grau-López
Lara Grau-López
Lara Grau-López
Alexithymia in Patients With Substance Use Disorders and Its Relationship With Psychiatric Comorbidities and Health-Related Quality of Life
Frontiers in Psychiatry
alexithymia
anxiety
depression
health-related quality of life
impulsivity
substance use disorder
title Alexithymia in Patients With Substance Use Disorders and Its Relationship With Psychiatric Comorbidities and Health-Related Quality of Life
title_full Alexithymia in Patients With Substance Use Disorders and Its Relationship With Psychiatric Comorbidities and Health-Related Quality of Life
title_fullStr Alexithymia in Patients With Substance Use Disorders and Its Relationship With Psychiatric Comorbidities and Health-Related Quality of Life
title_full_unstemmed Alexithymia in Patients With Substance Use Disorders and Its Relationship With Psychiatric Comorbidities and Health-Related Quality of Life
title_short Alexithymia in Patients With Substance Use Disorders and Its Relationship With Psychiatric Comorbidities and Health-Related Quality of Life
title_sort alexithymia in patients with substance use disorders and its relationship with psychiatric comorbidities and health related quality of life
topic alexithymia
anxiety
depression
health-related quality of life
impulsivity
substance use disorder
url https://www.frontiersin.org/articles/10.3389/fpsyt.2021.659063/full
work_keys_str_mv AT raulfpalmaalvarez alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT raulfpalmaalvarez alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT raulfpalmaalvarez alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT raulfpalmaalvarez alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT elenaroscucurull alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT elenaroscucurull alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT elenaroscucurull alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT elenaroscucurull alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT constanzadaigre alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT constanzadaigre alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT constanzadaigre alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT constanzadaigre alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT martapereaortueta alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT martapereaortueta alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT pedroserranoperez alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT pedroserranoperez alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT pedroserranoperez alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT nievesmartinezluna alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT annasalasmartinez alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT mariaroblesmartinez alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT mariaroblesmartinez alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT joseparamosquiroga alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT joseparamosquiroga alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT joseparamosquiroga alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT joseparamosquiroga alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT carlosroncero alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT carlosroncero alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT laragraulopez alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT laragraulopez alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT laragraulopez alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife
AT laragraulopez alexithymiainpatientswithsubstanceusedisordersanditsrelationshipwithpsychiatriccomorbiditiesandhealthrelatedqualityoflife